MSH Capital Advisors’s Amgen AMGN Stock Holding History

MSH Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Buy	1,022 +62	+6%	+$21.2K	0.06%	238
2026 Q1	$338K	Buy	960 +277	+41%	+$98.7K	0.07%	216
2025 Q4	$224K	Buy	+683	New	+$217K	0.05%	253
2022 Q4	–	Sell	-5,329	Closed	-$1.2M	–	195
2022 Q3	$1.2M	Buy	5,329 +25	+0.5%	+$6.06K	0.59%	59
2022 Q2	$1.29M	Sell	5,304 -102	-2%	-$25K	0.6%	60
2022 Q1	$1.31M	Buy	5,406 +210	+4%	+$48.3K	0.54%	63
2021 Q4	$1.17M	Buy	+5,196	New	+$1.1M	0.52%	64

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

MSH Capital Advisors's AMGN Position: Q2 2026 in Review

MSH Capital Advisors increased its Amgen (AMGN) stake by 6.5% in Q2 2026, buying an estimated $21.2K and bringing the position to 1,022 shares worth $370K. The position accounts for 0.06% of the portfolio, ranked #238.

MSH Capital Advisors first reported a position in AMGN in Q4 2021 and has held it in 7 quarters since. The position peaked at $1.31M in Q1 2022. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

MSH Capital Advisors held 1,022 shares of Amgen worth $370K as of Q2 2026.
MSH Capital Advisors bought 62 Amgen shares in Q2 2026, an estimated $21.2K.
Amgen made up 0.06% of MSH Capital Advisors's portfolio in Q2 2026, its #238 holding.
MSH Capital Advisors first reported a position in Amgen in Q4 2021 and has held it in 7 quarters since.
MSH Capital Advisors's Amgen position peaked at $1.31M in Q1 2022.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.